| Date | Title | Description |
| 13.02.2023 | Meet Vignesh Ravikumar, partner at Sierra Ventures | Sierra Ventures is an early stage firm with a focus on B2B and B2B2C companies
Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While there are more star... |
| 31.01.2023 | Paradigm Launches with $203M to Transform Clinical Trial Recruitment | A new startup co-incubated by ARCH Venture Partners and General Catalyst launched last week with $203 million in Series A funding.
The New York-based company, called Paradigm, is focused on improving patients’ access to clinical research. I... |
| 06.11.2022 | AI in Healthcare: What it Can do and What it Can’t | Staff Reporter, Tech Times 06 November 2022, 09:11 pm
(Photo : Pexels)
Artificial intelligence is transforming the healthcare sector. A research team at the Stevens Institute of Technology designed and built an AI-powered tool that can dete... |
| 28.05.2021 | StartUPDATES: New developments from healthcare startups | Blue Therapeutics has released the second part of a receptor-interactomics™ concept paper series, “Innate Proximity: inherent physicality of receptor interactions” by Ajay Yekkirala, CSO and co-founder of Blue Therapeutics.
As part of Blue’... |
| 07.04.2021 | Cardinal Health and Deep Lens Collaborate for AI-based Oncology Clinical Trial Matching | What You Should Know:
– Today, Deep Lens and Cardinal Health announced a strategic collaboration that will integrate Deep Lens’ AI-based clinical trial matching solution, VIPER, into community-based oncology practices throughout the Cardina... |
| 08.07.2020 | What Investors are Looking for in AI/ML | Advances in artificial intelligence (AI) have enabled machines to begin to outperform humans in areas like picking stocks, interpreting X-rays, and language translation. AI enables machines to perform human-like tasks with increasing degree... |
| 22.06.2020 | For Health Tech Startups, Data Is Their Lifeline Now More Than Ever | 73 Shares Email Facebook Twitter LinkedIn
By Vignesh Ravikumar, a principal at Sierra Ventures. Sierra is a Bay Area-based early-stage venture capital firm investing globally with a focus on next-generation enterprise and emerging technolog... |
| 22.06.2020 | For Health Tech Startups, Data Is Their Lifeline Now More Than Ever | 69 Shares Email Facebook Twitter LinkedIn
By Vignesh Ravikumar, a principal at Sierra Ventures. Sierra is a Bay Area-based early-stage venture capital firm investing globally with a focus on next-generation enterprise and emerging technolog... |
| 16.01.2020 | Sierra Ventures Year in Review – 2019
A Recap of 2019
Sierra Ventures Year in Review | A Recap of 2019 Sierra Ventures Year in Review
2019 was a big year for Sierra Ventures with the raise of our 12th Fund ($215M). We made 8 exciting new investments in Sierra XI and are looking forward to investing out of Sierra XII in the co... |
| 08.04.2019 | Deep Lens wraps up $14M Series A round to improve digital pathology platform | The Columbus, Ohio-based company said it intends to use the money to advance its AI-driven platform and scale its sales and marketing efforts to support continued growth.
“We will also add to the software development team to ensure that VIP... |
| 08.04.2019 | Deep Lens Lands $14M to Scale AI-Driven Digital Pathology Platform | Digital pathology startup Deep Lens lands $14M in Series A funding to scale AI-driven digital pathology platform
Deep Lens, Inc., a Columbus, OH-based AI-driven digital pathology company focused on clinical trial recruitment at the time of ... |
| 08.04.2019 | Deep Lens Closes $14M Series A Financing | Deep Lens, Inc., a Columbus, OH-based AI-driven digital pathology company focused on clinical trial recruitment at the time of diagnosis, closed a $14m Series A financing.
The round led by Northpond Ventures, with participation from existin... |
| 08.04.2019 | Deep Lens raises $14 million to improve clinical trial recruitment with AI | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Deep Lens, a Columbus, Ohio-based startup developing a precision medicine software suite, today announced that it’s raised $14 million ... |
| 08.04.2019 | Deep Lens raises $14 million to improve clinical trial recruitment with AI | Deep Lens, a Columbus, Ohio-based startup developing a precision medicine software suite, today announced that it’s raised $14 million in series A funding led by Northpond Ventures, with participation from existing investors Rev1 Ventures, ... |
| 05.03.2019 | A Recap of 2018 | 2018 was a successful year for Sierra Ventures. Sierra X had two significant exits in addition to the prior nine acquisitions, allowing us to more than return capital for that fund. We made 10 exciting new investments in Sierra XI, and our ... |
| 16.10.2018 | Term Sheet — Tuesday, October 16 | BIG MONEY
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundaries From ExtraHop
—
UBER IPO: Uber received proposals from Wall Street banks valuing the ride-hailing tech behemoth at as much as $120 billion i... |
| 15.10.2018 | Digital pathology startup Deep Lens raises $3.2M | |
| 15.10.2018 | Precision medicine startup DeepLens exits stealth mode with $3.2 million seed funding to globally deploy its flagship pathology product | Deep Lens, a cloud-based digital pathology startup that helps patients, pathologists and physicians work together to accelerate and optimize treatment, has emerged from the stealth mode with with $3.2 million seed financing. The new funding... |
| 12.10.2018 | Daily funding roundup - October 12th, 2018 | strongDM raised $1M; Deep Lens raised $3.2M; Rollick raised $8.3M; Nyotron raised $10M
strongDM: strongDM is a platform to define permissions and monitor access to any database. It's so easy, security is the convenient choice. strongDM clos... |
| 12.10.2018 | Deep Lens raises $3.2 million for AI cloud pathology platform | Dave Billiter, an Ohio native and graduate of Ohio Northern University and Columbus Southern University, joined Nationwide Children’s Hospital in 2004, where he led the health system’s informatics efforts. There, he oversaw the creation of ... |
| 12.10.2018 | Deep Lens Raises $3.2M in Seed Financing | Deep Lens, Inc., a Columbus, OH-based digital pathology startup, exited stealth mode with $3.2m in seed financing.
The round was led by Sierra Ventures, with participation from Rev1 Ventures and Tamarind Hill Fund. In conjunction with the f... |
| 12.10.2018 | Deep Lens raises $3.2 million for AI cloud pathology platform | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Dave Billiter, an Ohio native and graduate of Ohi... |
| 12.10.2018 | Digital pathology company exits stealth mode with $3.2M in funding | VIPER, which is currently available as a public beta, is a cloud-based digital pathology platform. It brings together artificial intelligence and advanced pathology workflows while also enabling peer-to-peer and pathologist-to-patient colla... |
| - | Digital pathology company exits stealth mode with $3.2M in funding | Deep Lens, a digital pathology startup, has emerged from stealth mode with $3.2 million in seed financing. Sierra Ventures led the funding round, while Rev1 Ventures and Tamarind-Hill Fund participated.
In a recent phone interview, Deep Len... |
| - | Deep Lens wraps up $14M Series A round to improve digital pathology platform | Deep Lens, a digital pathology company that emerged from stealth mode with $3.2 million last fall, has closed a $14 million Series A round of financing. The company said this brings its total funding to $17.5 million.
Northpond Ventures led... |
| - | StartUPDATES: New developments from healthcare startups | Blue Therapeutics has released the second part of a receptor-interactomics™ concept paper series, “Innate Proximity: inherent physicality of receptor interactions” by Ajay Yekkirala, CSO and co-founder of Blue Therapeutics.
As part of Blue’... |
